Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
0(0%)
Results Posted
10%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_4
8
73%
Ph phase_2
1
9%
Ph phase_3
1
9%

Phase Distribution

0

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
8(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(10)
Terminated(1)

Detailed Status

Completed10
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (10.0%)
Phase 31 (10.0%)
Phase 48 (80.0%)

Trials by Status

completed1091%
terminated19%

Recent Activity

0 active trials
Showing 5 of 11
completed

Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer

NCT05130125
completedphase_4

Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity

NCT03755973
completedphase_2

Lutropin Alfa in Women at Risk of Poor Response

NCT01112358
terminatedphase_4

Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles

NCT01816789
completedphase_4

Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist

NCT02412904
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05130125

Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer

Completed
NCT03755973Phase 4

Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity

Completed
NCT01112358Phase 2

Lutropin Alfa in Women at Risk of Poor Response

Completed
NCT01816789Phase 4

Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles

Terminated
NCT02412904Phase 4

Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist

Completed
NCT02046655Phase 4

Corifollitropin Alfa Compared to Daily rFSH in Poor Responders Undergoing ICSI

Completed
NCT01365936Phase 4

hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF

Completed
NCT01509833Phase 3

Efficacy of Low Dose hCG on Oocyte Maturity in Poor Responder Women Undergoing Intracytoplasmic Sperm Injection

Completed
NCT00844311Phase 4

Supplementation With Human Chorionic Gonadotropin (hCG) During Controlled Ovarian Stimulation With Recombinant Follicle-stimulating Hormone (FSH) for In Vitro Fertilisation

Completed
NCT00830492Phase 4

Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

Completed
NCT00829075Phase 4

Impact of Three Different Gonadotrophin Regimes on Egg Donation Program

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11